Technical Analysis for CLIN - Clinigen Group Plc

Grade Last Price % Change Price Change
F 618.5 -0.72% -4.50
CLIN closed down 0.72 percent on Thursday, June 24, 2021, on 65 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down
Historical CLIN trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
Stochastic Reached Oversold Weakness 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Narrow Range Bar Range Contraction -0.72%
Wide Bands Range Expansion -0.72%
Wide Bands Range Expansion -1.51%
1,2,3 Retracement Bearish Bearish Swing Setup -2.90%
Older End-of-Day Signals for CLIN ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
10 DMA Support 2 days ago
Fell Below Previous Day's Low 2 days ago
Down 2% 2 days ago
Down 1% 2 days ago
Fell Below 10 DMA 2 days ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Clinigen Group Plc Description

Clinigen Group plc is a United Kingdom-based pharmaceutical and services company. The Company's principal activities include management, sale and distribution of pharmaceutical products, which have associated expiry dates. The Company operates through five segments: Clinigen Clinical Trial Services (CTS), which sources commercial medical products for use in clinical studies, including comparator drugs, adjuvant drugs and rescue therapies; Idis Managed Access (MA), which is engaged in the consultancy, development, management and implementation of managed access programs for biotechnology and pharmaceutical companies; Idis Global Access (GA), which offers ethical access to post approval and short-supply medicines; Clinigen Specialty Pharmaceuticals (SP), which manufactures and distributes its own and in-licensed specialist, hospital-only medicines around the world, and Link Healthcare, which distributes pharmaceutical products in South Africa, and the Asia and Pacific region.


Sector: Healthcare
Industry: Medical Distribution
Keywords: Health Healthcare Pharmaceutical Consultancy Biotechnology Medicine Clinic Pharmaceuticals Hospital Drugs Clinical Trial Pharmaceutical Industry Therapies Rescue Clinical Research Pharmaceutical Products Medication Pharmaceutical Industry In China Pharmaceuticals Policy Design Of Experiments Medical Products Pharmaceutical Companies Idis Clinical Trial Services

Is CLIN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 891.79
52 Week Low 554.0
Average Volume 875,558
200-Day Moving Average 713.87
50-Day Moving Average 786.60
20-Day Moving Average 711.18
10-Day Moving Average 625.85
Average True Range 32.44
ADX 33.39
+DI 15.51
-DI 35.83
Chandelier Exit (Long, 3 ATRs) 794.46
Chandelier Exit (Short, 3 ATRs) 657.14
Upper Bollinger Bands 932.94
Lower Bollinger Band 489.41
Percent B (%b) 0.29
BandWidth 62.37
MACD Line -54.47
MACD Signal Line -49.35
MACD Histogram -5.1237
Fundamentals Value
Market Cap 822.78 Million
Num Shares 133 Million
EPS 10.20
Price-to-Earnings (P/E) Ratio 60.64
Price-to-Sales 1.72
Price-to-Book 1.92
PEG Ratio 0.00
Dividend 0.08
Dividend Yield 0.01%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 636.50
Resistance 3 (R3) 638.50 634.50 633.50
Resistance 2 (R2) 634.50 629.92 633.50 632.50
Resistance 1 (R1) 626.50 627.08 624.50 624.50 631.50
Pivot Point 622.50 622.50 621.50 621.50 622.50
Support 1 (S1) 614.50 617.92 612.50 612.50 605.50
Support 2 (S2) 610.50 615.08 609.50 604.50
Support 3 (S3) 602.50 610.50 603.50
Support 4 (S4) 600.50